Drug class
Vasoactive intestinal peptide (VIP) analogue; peptide VPAC-receptor agonist
Mechanism of action
A synthetic analogue of vasoactive intestinal peptide that activates VIP receptors, including VPAC1, and can promote smooth-muscle relaxation and vasoactive signalling.
General use cases
- Used in combination with phentolamine in locally authorised intracavernosal products for erectile dysfunction; the combination and route are product-specific.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
